李氏大药厂：上半年纯利增长7.5% 中期每股派息0.022港元

Group 1 - The company reported a revenue of HKD 695 million for the first half of 2025, representing a year-on-year increase of 5.5% [1] - The net profit for the same period was HKD 67.185 million, showing a year-on-year growth of 7.5% [1] - The company proposed an interim dividend of HKD 0.022 per share [1]